FDA Panel Recommends New Booster to Target Omicron Despite Concerns of 'Too Little Data' • Children's Health Defense

fda future framework covid vaccines feature

FDA Panel Recommends New Booster to Target Omicron Despite Concerns of ‘Too Little Data’

The U.S. Food and Drug Administration’s vaccine advisory panel voted 19 to 2 on Tuesday to add an Omicron component to COVID-19 boosters this fall, over objections by panel members and despite a lack of data.